CHRISTOPHER LAFLURE: Open Payments
NPI 1518070663 · GRAND RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$520 in 17 payments from 11 companies in 2025. Trend: 2023 $98 · 2024 $97 · 2025 $520
Food & beverage: $335Education: $185
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 3 | $127 |
| SEAGEN INC. | 1 | $100 |
| Endo USA, Inc. | 4 | $90 |
| ABBVIE INC. | 2 | $40 |
| UROGEN PHARMA, INC. | 1 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $26 |
| Novartis Pharmaceuticals Corporation | 1 | $26 |
| Teleflex LLC | 1 | $23 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $22 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: ERLEADA, XIAFLEX, BOTOX, JELMYTO, ORGOVYX, PLUVICTO, BARRIGEL, JOURNAVX.
Industry payments across MI — which companies pay providers there.
